Impact of race in a predominantly African-American population of patients with low/intermediate risk prostate cancer undergoing radical prostatectomy within an equal access care institution-Reference-Cited by-同舟云学术

Impact of race in a predominantly African-American population of patients with low/intermediate risk prostate cancer undergoing radical prostatectomy within an equal access care institution

Published:2014-06-27 Issue:10 Volume:46 Page:1941-1946
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Schreiber David,Levy Eric B.,Schwartz David,Rineer Justin,Wong Andrew,Rotman Marvin,Weiss Jeffrey P.

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s11255-014-0773-3.pdf

Reference17 articles.

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30

2. Chornokur G, Dalton K, Borysova M, Kumar N (2011) Disparities at presentation, diagnosis, treatment and survival in African American men affected by prostate cancer. Prostate 71(9):985–997

3. Hudson MA, Luo S, Chrusciel T et al (2014) Do racial disparities exist in the use of prostate cancer screening and detection tools for US Veterans? Urol Oncol 32(1):34.e9–34.e18

4. Skolarus TA, Chan S, Shelton JB et al (2013) Quality of prostate cancer care among rural men in the Vetrans Health Administration. Cancer 119(20):3629–3635

5. Sundi D, Ross AE, Humpreys EB et al (2013) African American men with very low risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol 31(24):2991–2997

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017;Cancer Medicine;2022-05-31

2. HSD17B7 gene in self‐renewal and oncogenicity of keratinocytes from Black versus White populations;EMBO Molecular Medicine;2021-06-29

3. Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8‐10) prostate cancer treated primarily by radical prostatectomy;Cancer;2021-03-15

4. Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer;Cancer Letters;2020-11

5. Race, tumor location, and disease progression among low‐risk prostate cancer patients;Cancer Medicine;2020-01-21